These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8632444)

  • 1. Morphological studies of pseudowollastonite for biomedical application.
    de Aza PN; Luklinska ZB; Anseau M; Guitian F; de Aza S
    J Microsc; 1996 Apr; 182(Pt 1):24-31. PubMed ID: 8632444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactivity of pseudowollastonite in human saliva.
    De Aza PN; Luklinska ZB; Anseau MR; Guitian F; De Aza S
    J Dent; 1999 Feb; 27(2):107-13. PubMed ID: 10071467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro bioactivity of laser ablation pseudowollastonite coating.
    De Aza PN; Fernández-Pradas JM; Serra P
    Biomaterials; 2004 May; 25(11):1983-90. PubMed ID: 14741612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone-like apatite layer formation on hydroxyapatite prepared by spark plasma sintering (SPS).
    Gu YW; Khor KA; Cheang P
    Biomaterials; 2004 Aug; 25(18):4127-34. PubMed ID: 15046903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic silicate active site and stereochemical match for apatite nucleation on pseudowollastonite bioceramic-bone interfaces.
    Sahai N; Anseau M
    Biomaterials; 2005 Oct; 26(29):5763-70. PubMed ID: 15949543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of wollastonite-poly(ethylmethacrylate co-vinylpyrrolidone) based materials for multifunctional devices.
    Rodríguez-Lorenzo LM; Carrodeguas RG; Rodríguez MA; De Aza S; Parra J; Román JS
    J Biomed Mater Res A; 2007 Jun; 81(3):603-10. PubMed ID: 17187391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro bioactivity of novel tricalcium silicate ceramics.
    Zhao W; Chang J; Wang J; Zhai W; Wang Z
    J Mater Sci Mater Med; 2007 May; 18(5):917-23. PubMed ID: 17216580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological and structural study of pseudowollastonite implants in bone.
    De Aza PN; Luklinska ZB; Martinez A; Anseau MR; Guitian F; De Aza S
    J Microsc; 2000 Jan; 197(Pt 1):60-7. PubMed ID: 10620149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ hydroxyapatite nanofiber growth on calcium borate silicate ceramics in SBF and its structural characteristics.
    Pu Y; Huang Y; Qi S; Chen C; Seo HJ
    Mater Sci Eng C Mater Biol Appl; 2015 Oct; 55():126-30. PubMed ID: 26117746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro hydroxyapatite forming ability and dissolution of tobermorite nanofibers.
    Lin K; Chang J; Cheng R
    Acta Biomater; 2007 Mar; 3(2):271-6. PubMed ID: 17234465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission electron microscopy of the interface between bone and pseudowollastonite implant.
    De Aza PN; Luklinska ZB; Anseau MR; Guitian F; De Aza S
    J Microsc; 2001 Jan; 201(Pt 1):33-43. PubMed ID: 11136437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro behavior of osteoblastic cells cultured in the presence of pseudowollastonite ceramic.
    Sarmento C; Luklinska ZB; Brown L; Anseau M; De Aza PN; De Aza S; Hughes FJ; McKay IJ
    J Biomed Mater Res A; 2004 May; 69(2):351-8. PubMed ID: 15058008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity of plasma-sprayed wollastonite coating in simulated body fluid.
    Liu X; Ding C
    J Biomed Mater Res; 2002 Feb; 59(2):259-64. PubMed ID: 11745561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactivity of calcium aluminate endodontic cement.
    Oliveira IR; Andrade TL; Jacobovitz M; Pandolfelli VC
    J Endod; 2013 Jun; 39(6):774-8. PubMed ID: 23683278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced apatite-forming ability and antibacterial activity of porous anodic alumina embedded with CaO-SiO2-Ag2O bioactive materials.
    Ni S; Li X; Yang P; Ni S; Hong F; Webster TJ
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():700-8. PubMed ID: 26478362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactive hydroxyapatite coatings on polymer composites for orthopedic implants.
    Auclair-Daigle C; Bureau MN; Legoux JG; Yahia L
    J Biomed Mater Res A; 2005 Jun; 73(4):398-408. PubMed ID: 15892136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro degradation, bioactivity, and cytocompatibility of calcium silicate, dimagnesium silicate, and tricalcium phosphate bioceramics.
    Ni S; Chang J
    J Biomater Appl; 2009 Aug; 24(2):139-58. PubMed ID: 18801892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of strontium incorporation into CaSiO3 ceramics on their physical and biological properties.
    Wu C; Ramaswamy Y; Kwik D; Zreiqat H
    Biomaterials; 2007 Jul; 28(21):3171-81. PubMed ID: 17445881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ca,P-rich layer formed on high-strength bioactive glass-ceramic A-W.
    Kokubo T; Ito S; Huang ZT; Hayashi T; Sakka S; Kitsugi T; Yamamuro T
    J Biomed Mater Res; 1990 Mar; 24(3):331-43. PubMed ID: 2156869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural comparison of dissolution and apatite precipitation on hydroxyapatite and silicon-substituted hydroxyapatite in vitro and in vivo.
    Porter AE; Botelho CM; Lopes MA; Santos JD; Best SM; Bonfield W
    J Biomed Mater Res A; 2004 Jun; 69(4):670-9. PubMed ID: 15162409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.